Search Result "2 (IDO)"
Regulation of Expression and Function of IDO in Human Dendritic Cells
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 1 Year: 2011 Page: 2222-2233
Author(s): A. Heitger
Indoleamine 2,3-dioxygenase (IDO): Biology and Target in Cancer Immunotherapies
Journal: Current Cancer Drug Targets
Volume: 16 Issue: 9 Year: 2016 Page: 755-764
Author(s): Senthamil R. Selvan,John P. Dowling,William K. Kelly,Jianqing Lin
Pharmacological Targeting of IDO-Mediated Tolerance for Treating Autoimmune Disease
Journal: Current Drug Metabolism
Volume: 8 Issue: 3 Year: 2007 Page: 245-266
Author(s): W. T. Penberthy
IDO and Clinical Conditions Associated with Depressive Symptoms
Journal: Current Drug Metabolism
Volume: 8 Issue: 3 Year: 2007 Page: 283-287
Author(s): Claudia Kohl, B. Sperner-Unterweger
Tryptophan Catabolism in IDO+ Plasmacytoid Dendritic Cells
Journal: Current Drug Metabolism
Volume: 8 Issue: 3 Year: 2007 Page: 209-216
Author(s): Francesca Fallarino, S. Gizzi, P. Mosci, U. Grohmann, P. Puccetti
Targeting Indoleamine 2,3-dioxygenase (IDO) to Counteract Tumour- Induced ImmuneDysfunction: From Biochemistry to Clinical Development
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 9 Issue: 2 Year: 2009 Page: 151-177
Author(s): S. Rutella, G. Bonanno, R. De Cristofaro
Development of New IDO Inhibitors with Coumarin Pyrimidine Scaffolds as the Potential Anti Cancer Agents
Journal: Current Bioactive Compounds
Volume: 16 Issue: 8 Year: 2020 Page: 1172-1180
Author(s): Radhika Chelamalla,Ajitha Makula
Indoleamine 2,3-dioxygenase (IDO)-activity in Severe Psychiatric Disor-ders: A Systemic Review
Journal: Current Topics in Medicinal Chemistry
Volume: 22 Issue: 25 Year: 2022 Page: 2107-2118
Author(s): Frederike T. Fellendorf,Elena M.D. Schönthaler,Eva Z. Reininghaus
IDO+ DCs and Signalling Pathways
Journal: Current Cancer Drug Targets
Volume: 13 Issue: 3 Year: 2013 Page: 278-288
Author(s): Yue Wang, Bao-Hong Yang, Hui Li, Shui Cao, Xiu-Bao Ren, Jin-Pu Yu
Plasma Indoleamine-2,3-Dioxygenase (IDO) is Increased in Drug-Naï ve Major Depressed Patients and Treatment with Sertraline and Ketoprofen Normalizes IDO in Association with Pro-Inflammatory and Immune- Regulatory Cytokines
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 19 Issue: 1 Year: 2020 Page: 44-54
Author(s): Hussein Kadhem Al-Hakeim,Ahmed Jasim Twayej,Arafat Hussein Al-Dujaili,Michael Maes